Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Protocells A Versatile Drug Delivery Platform

Abstract:
Imagine it would be possible to transport drugs by a shuttle which would be drawn to the desired destination as if by magic on an invisible thread. Upon arrival, a gate is opened by a specific key and the vehicle can get rid of its precious cargo. This kind of targeted drug delivery would enable controlled and specific enrichment of a therapeutic agent in the tissue or organ where it is actually needed and side effects could be reduced.

Protocells A Versatile Drug Delivery Platform

Germany | Posted on September 13th, 2012

In traditional drug delivery approaches, only a small amount of the drug reaches the part of the body where it is actually required. It is therefore of the utmost importance to better predict and influence the degree of specificity in targeted drug delivery concepts.

The clinical use of protein toxins like Ricin toxin as anti-cancer agents is often hindered by their immunogenicity which leads to a dosage restriction and represents a significant drawback for their clinical utility. To exploit the valuable features of this class of therapeutic agents, smart and innovative hybrid architectures have to be designed which elegantly circumvent these limitations and fulfill the requirements expected of modern therapeutic agents.

Researchers from the University of New Mexico and from the Sandia National Laboratories present a highly complex system as a versatile delivery platform that may enable protein toxin-based therapies to reach their full potential. The so-called "Protocell" combines a mesoporous silica core loaded with the toxic RTA (Ricin toxin A) with the features of liposomes. The particle core is coated with a lipid bilayer further modified with a targeting peptid for specific delivery, and an endosomolytical peptide for intracellular release.

RTA-loaded protocells show a 500-fold higher capacity for RTA than conventionally loaded liposomes and are stable under neutral pH conditions, unlike the uncoated loaded silica particles or the liposomes which rapidly lose their encapsulated RTA under neutral pH conditions. However, under a slightly acidic pH which reflects the physiological conditions in the endosomal orlysosomal pathway, the total amount of cargo is released within 24 hours.

Due to the coexistence of the endosomolytical and the targeting peptide, only the receptor-positive cells are specifically addressed and killed whereas the viability of other cells is maintained.

Thus, in terms of capacity, stability, and triggered release, these kinds of protocells represent a substantial improvement over conventionally produced liposomes and have the potential to address many limitations of state-of-the-art toxin-based therapies.

####

For more information, please click here

Copyright © Wiley-VCH Materials Science Journals

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Link to the original paper on Wiley Online Library:

Related News Press

News and information

A nano-roundabout for light December 10th, 2016

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Discoveries

A nano-roundabout for light December 10th, 2016

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Announcements

A nano-roundabout for light December 10th, 2016

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project